X
ACHEMA MIDDLE EAST 2026
Pharma Advancement
DDF Summit 2025
  • Home
  • Articles
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development
    idiopathic pulmonary fibrosis

    US FDA Approves Jascayd for Idiopathic Pulmonary Fibrosis

    Tissue Repair Drug

    FDA Clears Tissue Repair Drug AD-NP1 For Clinical Trials

    FastTrack Review

    US FDA Launches Fast-Track Review Scheme for Generic Drugs

    AI Based Drug Discovery

    Bristol Myers, Takeda, Astex to Back AI Based Drug Discovery

    wearable drug delivery devices

    Wearable Drug Delivery Devices for On-Demand Care

    biologic drug formulation stability

    Breakthroughs in Biologic Drug Formulation Stability

    high volume injectable formulations

    Overcoming Challenges in High-Volume Injectable Formulations

    lipid nanoparticles in RNA therapies

    Lipid Nanoparticles in RNA and Gene Therapies

    Breast Cancer Therapy

    US FDA Approves Breast Cancer Therapy Inluriyo by Eli Lilly

  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us
No Result
View All Result
  • Home
  • Articles
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development
    idiopathic pulmonary fibrosis

    US FDA Approves Jascayd for Idiopathic Pulmonary Fibrosis

    Tissue Repair Drug

    FDA Clears Tissue Repair Drug AD-NP1 For Clinical Trials

    FastTrack Review

    US FDA Launches Fast-Track Review Scheme for Generic Drugs

    AI Based Drug Discovery

    Bristol Myers, Takeda, Astex to Back AI Based Drug Discovery

    wearable drug delivery devices

    Wearable Drug Delivery Devices for On-Demand Care

    biologic drug formulation stability

    Breakthroughs in Biologic Drug Formulation Stability

    high volume injectable formulations

    Overcoming Challenges in High-Volume Injectable Formulations

    lipid nanoparticles in RNA therapies

    Lipid Nanoparticles in RNA and Gene Therapies

    Breast Cancer Therapy

    US FDA Approves Breast Cancer Therapy Inluriyo by Eli Lilly

  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us
No Result
View All Result
Pharma Advancement
No Result
View All Result
Home Manufacturing

Schreiner MediPharm combines expertise in innovative labels and integrated solutions with Edelmann

Content Team by Content Team
1st April 2019
in Manufacturing, News, Packaging & Logistic
Schreiner MediPharm combines expertise in innovative labels and integrated solutions with Edelmann

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Schreiner MediPharm has combined its expertise in innovative specialty labels and integrated solutions with folding box manufacturer Edelmann. The result is a smart medicine packaging solution with diverse digital features. It includes the BitSecure copy detection technology for fast and reliable product authentication as well as a closure seal with an integrated NFC chip and an additional void effect for tamper evidence.

“Pharmaceutical packaging of the future” serves more purposes than merely protecting and marking medicines. Smart packaging builds a digital bridge between the manufacturer, distributor and patient because, due to digital technologies, packaging is able to communicate. By means of diverse features, a demo version of a smart packaging solution jointly created by Schreiner MediPharm and the Edelmann Group shows pharmaceutical manufacturers the possibilities for authentication and tamper evidence of their products and thus for supply chain security and compliance with the EU Falsified Medicines Directives that has been in effect since February 2019.

BitSecure for Product Authentication
The BitSecure copy detection technology is a printed, digital security feature. BitSecure is based on a high-resolution, random pattern whose delicate details are not discernible by the naked eye. In an attempt to copy the small random pattern with a size of just a few millimeters, the printed image will suffer a loss in precision and optical details. The pattern can be authenticated quickly and flexibly on-site using a smartphone or handheld reader, and analyzed via related software. BitSecure is a reliable yet cost-efficient authentication technology. Due to its small size, it can be easily integrated into existing packaging or label designs.

NFC Closure Seal for Tamper Evidence
The closure seal with a void effect and an integrated NFC chip is more than a conventional seal for folding boxes. It combines analog and digital technologies and offers double tamper evidence: Before the seal’s initial opening, the user reads the NFC chip using a smartphone and related app to receive confirmation of the product’s authenticity. If the seal is peeled off, an irreversible void effect will appear. If the user opens the packaging without previously peeling off the seal, the seal will break along the perforation. If the NFC chip is read again, a warning on the smartphone will indicate that the packaging has been previously opened. This makes any tampering attempt clearly visible. Additionally, interactive applications for patient information and assistance may be integrated into the NFC chip.

 

Previous Post

DWK Life launches Kimble GLS 80 media bottle with multiport cap system

Next Post

China based innovation, CDMOs and Parallel Approvals driving huge growth in manufacturing at CPhI China

Related Posts

idiopathic pulmonary fibrosis
Americas

US FDA Approves Jascayd for Idiopathic Pulmonary Fibrosis

9th October 2025
Tissue Repair Drug
Clinical Trials

FDA Clears Tissue Repair Drug AD-NP1 For Clinical Trials

7th October 2025
FastTrack Review
Americas

US FDA Launches Fast-Track Review Scheme for Generic Drugs

7th October 2025
AI Based Drug Discovery
Drug Development

Bristol Myers, Takeda, Astex to Back AI Based Drug Discovery

1st October 2025
API Manufacturing Facility
Americas

AbbVie Launches New API Manufacturing Facility in Illinois

1st October 2025
U.S. manufacturing
Americas

Amgen to Expand U.S. Manufacturing with $650M Investment

30th September 2025
Next Post
CPHI CHINA 2019

China based innovation, CDMOs and Parallel Approvals driving huge growth in manufacturing at CPhI China

Qucik Links

  • Drug Development
  • Manufacturing
  • News
  • Events & Conferences
  • Newsletter Archive
Pharma Advancement

About Us

Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.

Subscribe Us

System

  • Search
  • Sitemap
  • RSS Feed

Resources

  • Advertise with us
  • Contact Us
  • Download Mediapack
  • Newsletters Archive

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

No Result
View All Result
  • Home
  • Articles
  • Drug Development
  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

Login to your account below

Forgotten Password?

Fill the forms bellow to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In